Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Report Date
Mr. Vijay B. SamantPresident & CEO1,141,5631.25%2015-10-12
Dr. Larry R. Smith,PhDVP, Vaccine Research242,0550.26%2015-10-12
Dr. Igor P. Bilinsky, PhDSr VP, Corporate Development193,7980.21%2015-07-13
Mr. Anthony A. RamosVP, Chief Accounting Officer146,9280.16%2015-10-23
Jill M. BroadfootSr Vice President, CFO, Sec145,6490.16%2013-04-01
Dr. Alain P. Rolland,Pharm.D.,PhDExec VP, Product Development127,5830.14%2013-08-22
Dr. R. Gordon Douglas,M.D.Director108,2810.12%2015-05-21
Dr. Robert C. Merton,PhDDirector90,7810.1%2015-05-21
Mr. Gary A. LyonsDirector78,281less than 0.1%2015-05-21
Dr. David C. Kaslow,M.D.Chief Scientific Officer43,405less than 0.1%2006-02-22

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Ramos Anthony AlanVP, Chief Accounting Officer2015-10-23Sell193146,928$0.390.117.95146,928 (Direct)
SMITH LAWRENCE RUSSELLVP, Vaccine Research2015-10-12Sell974242,055$0.430.46.98242,055 (Direct)
(Click for the stocks that their CEOs have bought)
2015-10-12Sell4,7381,141,563$0.411.912.21,141,563 (Direct)
Ramos Anthony AlanVP, Chief Accounting Officer2015-07-23Sell194147,121$0.620.1-25.81147,121 (Direct)
SMITH LAWRENCE RUSSELLVP, Vaccine Research2015-07-13Sell974243,029$0.70.7-34.29243,029 (Direct)
SAMANT VIJAY BPresident & CEO2015-07-13Sell4,7371,146,301$0.73.3-34.291,146,301 (Direct)
BILINSKY IGORSr VP, Corporate Development2015-07-13Sell1,258193,798$0.70.9-34.29193,798 (Direct)
Ramos Anthony AlanVP, Chief Accounting Officer2015-04-23Sell193147,315$1.010.2-54.46147,315 (Direct)
SMITH LAWRENCE RUSSELLVP, Vaccine Research2015-04-13Sell974244,003$0.930.9-50.54244,003 (Direct)
BILINSKY IGORSr VP, Corporate Development2015-04-13Sell1,257195,056$0.931.2-50.54195,056 (Direct)
SAMANT VIJAY BPresident & CEO2015-04-13Sell4,7381,151,038$0.934.4-50.541,151,038 (Direct)
SAMANT VIJAY BPresident & CEO2015-03-30Sell55,0001,155,776$0.9150.1-49.451,155,776 (Direct)
Ramos Anthony AlanVP, Chief Accounting Officer2015-01-21Sell428147,508$1.090.5-57.8147,508 (Direct)
SAMANT VIJAY BPresident & CEO2015-01-13Sell4,737910,776$1.125.3-58.93910,776 (Direct)
SMITH LAWRENCE RUSSELLVP, Vaccine Research2015-01-12Sell1,912174,977$1.162.2-60.34174,977 (Direct)
BILINSKY IGORSr VP, Corporate Development2015-01-12Sell1,335126,313$1.161.5-60.34126,313 (Direct)
Ramos Anthony AlanVP, Chief Accounting Officer2014-10-21Sell42887,936$1.180.5-61.0287,936 (Direct)
SAMANT VIJAY BPresident & CEO2014-10-13Sell4,738936,513$1.135.4-59.29936,513 (Direct)
BILINSKY IGORSr VP, Corporate Development2014-10-13Sell1,335127,648$1.081.4-57.41127,648 (Direct)
SMITH LAWRENCE RUSSELLVP, Vaccine Research2014-10-13Sell1,912176,889$1.082.1-57.41176,889 (Direct)

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column) and "Shares Owned Following This (Direct & Indirect)" transactions (sixth column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership